Mode
Text Size
Log in / Sign up
N/A Completed N=20 Treatment

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease

Source: ClinicalTrials.gov NCT02371785 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcomePrimary: Device Technical Success — 29 lesions

Summary

This study evaluates the performance of the CorPath 200 System to deliver guide wires and balloons to blockages in the arteries of the leg.

Outcome Measures

OutcomeResultp-value
PRIMARY
Device Technical Success
29 —
PRIMARY
Adverse Events
— —
SECONDARY
Clinical Procedural Success
20 —
SECONDARY
Fluoroscopy Time
6.8 —
SECONDARY
Contrast Volume
73.3 —
SECONDARY
Total Procedure Time
45.5 —
SECONDARY
Interventional Procedure Time
23.4 —

Eligibility Criteria

Inclusion Criteria

  • General Inclusion
  • At least 18 years of age;
  • Symptomatic disease: presence of critical limb ischemia (including tissue loss or rest pain), or lifestyle-limiting claudication requiring intervention in iliac and/or superficial femoral arteries;
  • The subject or the legally authorized representative has been informed of the nature of the study and agrees to its provisions and has provided written informed consent.
  • Angiographic Inclusion

Presence of superficial femoral artery and/or iliac stenosis (>50%) or occlusion of up to 50 mm in length as determined by angiogram prior to index interventional procedure.

Exclusion Criteria

  • General Exclusion
  • Failure/inability/unwillingness to provide informed consent;
  • Target vessel has been previously treated with bypass;
  • Has an abdominal aortic aneurysm contiguous with the iliac artery target lesion;
  • Has contraindication to anticoagulation;
  • Has bleeding or a hypercoagulability disorder;
  • Thrombocytopenia;
  • Elevated international normalized ratio (>1.5);
  • Elevated serum creatinine (≥2.5 mg/dL);
  • Active infection;
  • Contraindication to contrast; or
  • Enrolled in concurrent clinical study.
  • Angiographic Exclusion
  • Target vessel:
  • shows evidence of previous dissection or perforation, or
  • has adjacent acute thrombus;
  • Lesion is highly calcified;
  • Lesion requires use of any atherectomy device during the procedure;
  • Has a pre-existing target artery aneurysm or perforation or dissection of the target artery prior to initiation of the interventional procedure.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02371785). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search